1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Now what?!

Discussion in 'Healthtronics' started by Anonymous, Jan 10, 2014 at 2:27 AM.

  1. Anonymous

    Anonymous Guest

    What does this mean for the future?

    1/9/2014 8:15 AM ET
    Endo Health Solutions (ENDP: Quote) has agreed to divest its HealthTronics business to Altaris Capital Partners, LLC for an upfront cash payment of $85 million, subject to cash and other working capital adjustments. Further, Endo would receive rights to additional cash payments of up to $45 million based on the future operating performance of HealthTronics for up to $130 million.

    Earlier, the company divested two operating units of HealthTronics, its image guided radiation therapy or IGRT and its anatomical pathology laboratory businesses, for around $25 million.

    Today's transaction and the prior announced sale of HealthTronics' anatomical pathology business and IGRT business completes Endo's full divestiture of all HealthTronics businesses. The transaction may close in the first quarter of 2014, including the expiration or termination of any applicable waiting periods under applicable competition laws.
  2. Anonymous

    Anonymous Guest

    As an employee it means that you are screwed.